More than 60% of the S&P-listed companies have reported earnings, and the results are well above expectations. It’s safe to ...

Goldman Sachs updated its outlook on McDonald's shares (NYSE:MCD), increasing the price target to $335 from the previous $313. The firm continues to hold a Neutral rating on the fast-food giant's ...

Following Q3FY25 results, Eicher Motors’ stock dropped nearly 7% as Goldman Sachs lowered its target price. The company ...

Gold was higher in the early Asian session, aided by prospects of demand for the precious metal as a hedge against inflation.

Goldman Sachs initiated coverage on Silence Therapeutics (NASDAQ:SLN), currently trading at $4.92 with a market cap of $232.3 million, with a Sell rating and a price target of $6.00. According to ...

Peloton Interactive, Inc. (NASDAQ:PTON – Get Free Report) shares were up 7.2% during mid-day trading on Monday after The ...

S&P 500 earnings per share could decline 1%-2% for each five percentage-point increase in the US tariff rate, Goldman Sachs ...

Hedge fund stock-pickers lost billions of dollars on Monday in a rout in global technology shares sparked by the emergence of ...

Shares of India's state-run oil refiners surged up to 5% after analysts at Macquarie and Goldman Sachs raised ratings and ...

We recently compiled a list of the 10 Large-Cap Stocks Insiders Are Buying Recently. In this article, we are going to take a ...

Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...